Form 4: Farallon Funds Reduce Lantheus Holdings Stake

Farallon Capital Management affiliated funds significantly reduced their indirect beneficial ownership in Lantheus Holdings, Inc. through two large common stock sales in August 2025.

Summary

• Reporting persons, including Rajiv A. Patel and other managing members of Farallon Capital Management, L.L.C., filed a Form 4 for Lantheus Holdings, Inc. (LNTH).
• The filing indicates sales of common stock by investment funds affiliated with Farallon Capital Management (the "Farallon Funds").
• On August 19, 2025, 41,000 shares of common stock were sold at $55.34 per share.
• On August 20, 2025, 3,365,000 shares of common stock were sold at a weighted average price of $56.15 per share, with prices ranging from $56.14 to $56.55.
• Following these transactions, the indirect beneficial ownership of the Farallon Funds in Lantheus Holdings, Inc. decreased from 6,842,227 shares to 3,477,227 shares.
• The reporting persons are identified as members of a group owning 10% of Lantheus Holdings, Inc.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a significant reduction in stake by a major institutional investor, which can be interpreted as a loss of confidence or a strategic exit by a sophisticated market participant. While not directly indicative of company performance, such a large sale by a 10% owner is generally viewed unfavorably by the market.

Negatives

• A significant reduction in indirect beneficial ownership by a major institutional investor group (Farallon Funds), selling a total of 3,406,000 shares.
• Such large sales by a 10% owner group could signal a change in investment strategy or a less favorable outlook on the company's future prospects by that group.

Risks

• Potential negative market perception due to a large institutional investor group reducing its stake, which could lead to downward pressure on the stock price.
• Reduced institutional support or oversight from a significant shareholder group.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This filing reflects a specific transaction by an institutional investor in a healthcare company (Lantheus Holdings, Inc. is a radiopharmaceutical company). Large sales by significant shareholders can sometimes precede or coincide with shifts in industry dynamics or company-specific performance, but this filing alone does not provide such context.

Related Party Transactions

• The reported transactions involve sales of common stock by investment funds affiliated with the reporting persons (Farallon Funds), which are considered related parties to the individuals listed as reporting persons or managing members.

Stakeholder Impact

• Shareholders: Existing shareholders may react negatively to the news of a large institutional investor reducing its stake, potentially leading to downward pressure on the stock price.

Next Steps

• The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Key Dates

Recommendation

The significant reduction in beneficial ownership by a major institutional investor group like Farallon Capital Management, selling over 3.4 million shares, is a strong negative signal. Such a large divestment by a sophisticated 10% owner often indicates a loss of conviction in the company's future prospects or a strategic reallocation of capital away from the stock. This action could lead to negative market sentiment and downward pressure on the share price, making a "sell" recommendation appropriate for investors looking to avoid potential losses or re-evaluate their position.

Keywords

Lantheus Holdings, LNTH, Farallon Capital Management, SEC Form 4, Insider Selling, Beneficial Ownership, Institutional Investor, Stock Sale, Equity Transaction